The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 2001

• Citation: S.I. 2001/3849
• Sections: 2

Section 1 Citation and commencement

These Regulations may be cited as the Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 2001 and shall come into force on 24th December 2001.

Section 2 Amendment of regulation 8 of the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980

In regulation 8 of the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980 (pack size on retail sale or supply of certain medicinal products on a general sale list)—

(a) in paragraph (1), for “paragraphs (2) to (2I) and (3)” there is substituted “paragraphs (2) to (2L) and (3)”;

(b) in paragraph (2), for sub-paragraph (b) there is substituted—

(b) in the case of tablets that are not effervescent—

(i) where they are enteric-coated, contain aspirin only, and the amount of aspirin in each tablet does not exceed 75 milligrams, not more than 28 tablets,

(ii) where they contain aloxiprin, or aspirin or paracetamol or a combination of any or all of those substances, and do not satisfy the conditions specified in head (i) of this sub-paragraph, not more than 16 tablets;

(c) in paragraph (2B) after sub-paragraph (d) add the following sub-paragraph—

(e) in the case of liquid preparations of ibuprofen, individual unit doses of not more than 5 millilitres each to a maximum of 20 unit doses.

(d) after paragraph (2I) there are inserted the following paragraphs—

(2J) Where a medicinal product for human use containing cetirizine hydrochloride is sold by retail in the course of a business elsewhere than at a registered pharmacy or is so offered or exposed for sale by retail or so supplied in circumstances corresponding to retail sale, the product shall be presented for sale in a separate and individual container or package containing not more than 7 tablets.

(2K) Where a medicinal product for human use containing loratadine is sold by retail in the course of a business elsewhere than at a registered pharmacy or is so offered or exposed for sale by retail or so supplied in circumstances corresponding to retail sale, the product shall be presented for sale in a separate and individual container or package containing not more than 7 tablets.

(2L) Where a medicinal product for human use containing ibuprofen lysine is sold by retail in the course of a business elsewhere than at a registered pharmacy or is so offered or exposed for sale by retail or so supplied in circumstances corresponding to retail sale, the product shall be presented for sale in a separate and individual container or package containing not more than 16 tablets.